Inventor · disambiguated record
Frank Bymaster
Also filed as: BYMASTER FRANK
2 granted patents·13 pending applications·4 citations·filing 2011–2024
44Inventor score
Files withMCKINNEY ANTHONY ALEXANDER7MCKINNEY ANTHONY4ETHISMOS RES INC1EUTHYMICS BIOSCIENCE INC1NEUROVANCE INC1
Top patents by PatentIndex Score
15 records- 0180US9566264B2Combinations and methodsEUTHYMICS BIOSCIENCE INC·Filed 2014·Granted Feb 14, 2017·4 cites·23 claims
- 0277US2024409514A1Methods for inhibiting native and promiscuous uptake of monoamine neurotransmittersETHISMOS RES INC·Filed 2024·Application pending·0 cites
- 0365US2021161863A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2020·Application pending·0 cites
- 0464US2021047268A1Methods for inhibiting native and promiscuous uptake of monoamine neurotransmisttersMCKINNEY ANTHONY·Filed 2020·Application pending·0 cites
- 0562US12042481B2Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2021·Granted Jul 23, 2024·0 cites·13 claims
- 0662US2018215710A1Methods for inhibiting native and promiscuous uptake of monoamine neurotransmittersMCKINNEY ANTHONY·Filed 2017·Application pending·0 cites
- 0762US2014228421A1Methods For Inhibiting Native And Promiscuous Uptake Of Monoamine NeurotransmittersMCKINNEY ANTHONY·Filed 2013·Application pending·0 cites
- 0858US2019358199A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2018·Application pending·0 cites
- 0956US2016199347A1Methods for inhibiting native and promiscuous uptake of monoamine neurotransmittersMCKINNEY ANTHONY·Filed 2015·Application pending·0 cites
- 1055US2014039029A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2013·Application pending·0 cites
- 1155US2018256542A1Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2017·Application pending·0 cites
- 1254US2014206740A1Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine NeurotransmittersNEUROVANCE INC·Filed 2013·Application pending·0 cites
- 1351US2012258994A1Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine NeurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2011·Application pending·0 cites
- 1451US2013123238A1Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2012·Application pending·0 cites
- 1540US2016346249A1Use of amitifadine, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in methods and compositions with enhanced efficacy and reduced metabolic side effects and toxicity for treatment of depression and other central nervous system disorders and conditions affected by monoamine neurotransmittersMCKINNEY ANTHONY ALEXANDER·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Bymaster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →